Last reviewed · How we verify

NCT05297656

The Effect of Instrument Assisted Soft Tissue Mobilization in Female Patients With Myofascial Pain Syndrome

Completed NA Last updated 26 December 2023
What this trial tests

NA trial testing Instrument Assisted Soft Tissue Mobilization in Myofascial Pain in 75 participants. Completed in 15 October 2023.

Timeline
8 April 2022
Primary endpoint
15 September 2023
15 October 2023

Quick facts

Lead sponsorKirsehir Ahi Evran Universitesi
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment75
Start date8 April 2022
Primary completion15 September 2023
Estimated completion15 October 2023
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Kirsehir Ahi Evran Universitesi — full company profile →

Who can join

Adults 18 to 45, female only, with Myofascial Pain or Instrument Assisted Soft Tissue Mobilization. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primer aim of this study is to demonstrate the effecti of instrument assisted soft tissue mobilization on pain, functionality, quality of life and depression in the treatment of female patients with myofascial pain syndrome due to active trigger points in the upper trapezius muscles

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Short-term results of instrument-assisted soft tissue mobilization in female patients with myofascial pain syndrome: A randomized blinded sham-controlled study.
    Cigdem-Karacay B, Sahbaz T, Gumusay D, Kodak MI, et al · · 2025 · PMID 41717508 · DOI 10.5606/tftrd.2025.15466

Verify or expand the search:

Other trials of Instrument Assisted Soft Tissue Mobilization

Trials testing the same drug.

Other recruiting trials for Myofascial Pain

Currently open trials in the same condition.

Other Kirsehir Ahi Evran Universitesi trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05297656.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing